STOCK TITAN
  1. Home
  2. Sec-filings
  3. NTRA
  4. [Form 4] Natera, Inc. Insider Trading Activity

Natera (NASDAQ: NTRA) co-founder’s trusts sell 1,500 shares

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Natera, Inc. insider Sheena Jonathan, a director and co‑founder, reported pre‑planned sales of common stock held by family trusts. Caraluna 1 and Caraluna 2 Trusts sold a total of 1,500 shares on July 15, 2026 at weighted‑average prices between $272.56 and $276.38 per share under a Rule 10b5-1 trading plan adopted June 7, 2024. The shares are held for trust beneficiaries, and Jonathan disclaims beneficial ownership. A separate holdings entry reports 246,202 common shares held directly.

Positive

  • None.

Negative

  • None.
Insider Sheena Jonathan
Role Director
Sold 1,500 shs ($411K)
Type Security Shares Price Value
Sale Common Stock 450 $273.0473 $123K
Sale Common Stock 90 $274.2589 $25K
Sale Common Stock 170 $275.2644 $47K
Sale Common Stock 40 $276.38 $11K
Sale Common Stock 390 $273.0088 $106K
Sale Common Stock 100 $273.684 $27K
Sale Common Stock 180 $274.9858 $49K
Sale Common Stock 80 $276.015 $22K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 18,332 shares (Indirect, By Caraluna 1 Trust); Common Stock — 246,202 shares (Direct)
Footnotes (1)
  1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.56 to $273.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.87 to $274.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.99 to $275.65 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.56 to $273.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.56 to $273.87 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.57 to $275.2150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.65 to $276.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold 1,500 shares Common stock sold on July 15, 2026 by family trusts
Sale price range $272.56–$276.38 per share Weighted-average price ranges across multiple open-market sales
Direct holdings 246,202 shares Common stock reported as held directly by the reporting person
Caraluna 1 Trust holdings 18,332 shares Indirect common stock holdings after one sale on July 15, 2026
Caraluna 2 Trust holdings 18,392 shares Indirect common stock holdings after one sale on July 15, 2026
Rule 10b5-1 plan adoption June 7, 2024 Adoption date of trading plan governing the reported sales
Rule 10b5-1 trading plan regulatory
"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The reported price in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership over such securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
open market or private transaction financial
"Sale in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transactions did Natera (NTRA) report on July 15, 2026?
Natera reported that family trusts associated with director and co‑founder Sheena Jonathan sold 1,500 common shares on July 15, 2026. The sales were executed in multiple trades, and a separate holdings line shows 246,202 shares of common stock reported as held directly.

How many Natera (NTRA) shares were sold and at what prices?
Caraluna 1 and Caraluna 2 Trusts sold a combined 1,500 Natera shares. Weighted‑average sale prices for the transactions ranged between $272.56 and $276.38 per share, reflecting multiple open‑market trades grouped into several price brackets disclosed in the footnotes.

Who executed the Natera (NTRA) share sales and who benefits?
The shares were sold by Caraluna 1 Trust and Caraluna 2 Trust, entities associated with reporting person Sheena Jonathan. The stock is held for the benefit of the trusts’ beneficiaries, and Jonathan disclaims beneficial ownership of these indirectly held securities.

Were the Natera (NTRA) insider sales made under a Rule 10b5-1 plan?
Yes. The filing states that the sales were effected under a Rule 10b5-1 trading plan. The plan was adopted by the reporting person on June 7, 2024, and the Form 4’s Rule 10b5‑1 checkbox is marked as affirming trades under such a plan.

What Natera (NTRA) holdings does Sheena Jonathan report after these transactions?
A holdings entry reports 246,202 common shares held directly by the reporting person. Individual transaction lines also show indirect trust positions, including 18,332 shares for Caraluna 1 Trust and 18,392 shares for Caraluna 2 Trust following specific reported sales.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sheena Jonathan
(Last)(First)(Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
(Street)
AUSTIN TEXAS 78753
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)XOther (specify below)
CO-FOUNDER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock246,202D
Common Stock07/15/2026S450(1)D$273.0473(2)18,332IBy Caraluna 1 Trust(3)
Common Stock07/15/2026S90(1)D$274.2589(4)18,242IBy Caraluna 1 Trust(3)
Common Stock07/15/2026S170(1)D$275.2644(5)18,072IBy Caraluna 1 Trust(3)
Common Stock07/15/2026S40(1)D$276.3818,032IBy Caraluna 1 Trust(3)
Common Stock07/15/2026S390(1)D$273.0088(6)18,392IBy Caraluna 2 Trust(3)
Common Stock07/15/2026S100(1)D$273.684(7)18,292IBy Caraluna 2 Trust(3)
Common Stock07/15/2026S180(1)D$274.9858(8)18,112IBy Caraluna 2 Trust(3)
Common Stock07/15/2026S80(1)D$276.015(9)18,032IBy Caraluna 2 Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.56 to $273.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.87 to $274.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.99 to $275.65 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.56 to $273.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.56 to $273.87 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.57 to $275.2150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.65 to $276.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact07/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR